Introduction {#Sec1}
============

Many cancer patients have (multiple) symptoms that can affect their feeling of well-being as well as their physical and social functioning. One of the most feared and burdensome physical symptom in cancer patients is pain. A recent review has shown that the prevalence of pain in cancer patients is still high: 64% in patients with metastatic, advanced, or terminal disease and 59% in patients on anticancer treatment \[[@CR1]\].

Factors relating to ineffective pain management fall into three categories: the health care system, health care providers, and patients \[[@CR2]\]. In the health care system, more attention is focused on "curing" cancer patients than on "caring" for them; this includes symptom management \[[@CR3]\]. Health care providers tend to show a lack attention for and knowledge about pain management \[[@CR4]--[@CR11]\] and, as a consequence, do not always treat pain according the World Health Organization guidelines \[[@CR5], [@CR10]\]. Patients generally lack knowledge about pain and pain management and are reluctant to report pain to their physician \[[@CR11], [@CR12]\]. Fears such as drug addiction, tolerance, and concerns about side effects also influence their intake of pain medication \[[@CR6], [@CR13]--[@CR16]\]. However, patients indicated that they would appreciate help with their physical and psychosocial problems and would like to receive information on this \[[@CR17]--[@CR19]\].

In the health care provider category, Goldberg and Morison conducted a systematic review of institutional interventions designed to improve the assessment and treatment of pain in cancer patients \[[@CR20]\]. This review included three trials that studied the effects of education for nurses on pain-related topics \[[@CR21]--[@CR23]\]. They concluded that these education sessions improved nurses' knowledge of pain and their attitudes toward it \[[@CR20]\]. However, these interventions did not lead to any significant decrease in the severity of pain in their patients \[[@CR20]\]. None of the randomized controlled trials (RCTs) specifically targeted other health care providers or physicians.

In the present study, we focused on patient-related factors in the knowledge and management of pain. A review of 17 RCTs on pain and pain management education for patients \[[@CR24]--[@CR40]\] suggested that tailored education counseling sessions directed at patients improved pain scores \[[@CR24]--[@CR26], [@CR29]--[@CR31], [@CR33], [@CR34], [@CR37], [@CR38], [@CR40]\] and altered any negative beliefs and misconceptions about pain \[[@CR25], [@CR26], [@CR29], [@CR30], [@CR32], [@CR33], [@CR37], [@CR39]\]. In 12 studies, pain education was provided by nurses \[[@CR24], [@CR25], [@CR27]--[@CR29], [@CR31]--[@CR33], [@CR35]--[@CR37], [@CR39]\]; in two studies, pain education was provided by other health care educators (e.g., research assistants, master students) \[[@CR26], [@CR30]\]; in two other studies, this aspect was not mentioned \[[@CR34], [@CR38]\]; and in the final study, a video was shown \[[@CR40]\]. Although the results of the patient-related RCTs were generally positive, there is still a need to gain more insight into the efficacy of pain education programs (PEPs) \[[@CR31]\]. There were methodological flaws in many areas in existing RCTs. In most studies, only the short-term effects were measured \[[@CR25], [@CR26], [@CR28]--[@CR31], [@CR34], [@CR38], [@CR40]\]. It is not clear whether short-term effects are sustained over longer periods of time. The education programs were generally fairly light (e.g., one face-to-face education session or one session combined with one or more telephone calls) \[[@CR24]--[@CR26], [@CR32]--[@CR35], [@CR37]--[@CR40]\], while it is well-known that patients and their family care providers require ongoing assistance with problem-solving in order to optimize their pain management regimen \[[@CR41]\]. Little is known about which subgroups gain the most from PEPs. This knowledge is necessary in order to tailor education programs and to maximize their effectiveness \[[@CR42]\]. Only one study indicated that the educational level of patients might influence the effects of PEPs \[[@CR43]\]. Only a very small proportion of the studies incorporated variables such as gender, age, and stage of the disease \[[@CR32], [@CR33]\]. None of the studies mentioned incorporated pain scores at baseline or anxiety and depression scores at baseline, although depression and pain form a well-known cluster \[[@CR44]\] and depressive disorders can affect compliance \[[@CR45]\]. The study population was small in almost half the RCTs with less than 35 participants in the intervention and control groups \[[@CR26], [@CR29], [@CR30], [@CR34]--[@CR36], [@CR40]\]. Attention was paid to communication between the nurses who gave the education and the treating physicians in only one study \[[@CR25]\], although continuity of care and communication between health care providers is known to be of major importance in the pain management process \[[@CR43]\].

In the present study, we tried to avoid making any of the above-mentioned methodological errors. Our aim was to evaluate how an intensive home-based PEP given by nurses affected the short-term and long-term effects of levels of pain, pain knowledge, quality of life, anxiety, and depression.

Materials and methods {#Sec2}
=====================

Source population {#Sec3}
-----------------

Patients were recruited from two sources: Firstly, from our previous prevalence study on pain and other symptoms in the province of Limburg, situated in the south of The Netherlands. The outpatients who scored 4 or higher on the pain intensity scale (range 0--10, 10 = worst pain) and who gave their written consent to participate in the next research project were asked to participate in this intervention study. This resulted in 54 patients. Secondly, patients were recruited by nurses and physicians working at outpatient clinics and the radiotherapy department. This resulted in 65 patients. A total 120 patients were included.

Patients were eligible if (1) they had been diagnosed with cancer, (2) they had been informed of their diagnosis, (3) they were aged 18 years or more, (4) they were able to understand and complete the questionnaire, (5) they had a "present" pain score of 4 or higher on a scale of from 0 to 10, and (6) they had agreed to participate in the study. Treatment stages included curative anticancer treatment, palliative anticancer treatment, and no further treatment options available. Patients were excluded if they had completed their curative anticancer treatment before the year 2000.

The study was approved by the Medical Ethics Committee of the University Hospital Maastricht. All the participants gave written informed consent.

Intervention {#Sec4}
------------

All patients were randomly allocated to the intervention group (*n* = 58) or the control group (*n* = 62), based on a computer-generated randomization procedure.

Patients in the control group received their usual care from their treating physician. Patients in the intervention group received specialized nursing care at home, at the same time as the care received from their treating physician (Fig. [1](#Fig1){ref-type="fig"}). This specialized care included the PEP and the monitoring of symptoms other than pain. Fig. 1Study design

The PEP was developed by De Wit et al. \[[@CR37]\] and consists of the following three components: (1) enhancement of patients' pain knowledge and pain management by means of a brochure, (2) instruction of patients as to how they should record their pain intensity in a pain diary, and (3) stimulation of patients' help-seeking behavior. An extensive description of the PEP can be found in the article in which it originally appeared \[[@CR37]\]. In the intervention group, palliative care nurses made three home visits, each lasting 1--1.5 h.

The pain brochure provides information on the following topics: possible causes of pain, pain control, nonadherence, misconceptions, and various nonpharmacological pain management techniques (cold, heat, relaxation, and massage). This brochure was tested in an earlier study \[[@CR46]\].

### First home visit {#Sec5}

The first home visit took place within 1 week of the baseline measurement. Intake data were recorded by the nurses in order to tailor the PEP to the patient's situation. These data were connected with intensity of pain, location of pain, type of pain, prescription of medication, adherence to medication, emotional well-being, and other physical symptoms. A pain brochure was handed to the patient and, if possible, studied in the presence of a family caregiver. Patients were invited to ask questions. They also received a pain diary with a clear explanation on how to record their pain intensity twice daily using a numerical rating scale from 0 to 10. If any pain problems or other physical and emotional symptoms arose, patients were encouraged to contact their health care provider.

After the first visit, the nurses reported their findings to the treating physician in writing. If necessary, advice was given with regard to pain medication, in all cases in consultation with a specialist in the pain treatment of oncology patients. This advice consisted of starting new pain medication, increasing the dosage of pain medication, or changing to a different pain medication regimen and was enclosed with their report.

### Second home visit {#Sec6}

During the second home visit, which took place in week 3, the nurse reviewed the pain intensity scores in the pain diary in order to detect any changes in pain intensity levels. Any changes in type of pain, location of pain, prescription of pain medication, or adherence to medication were also reviewed. Patients were asked whether they had read the "pain brochure" themselves and had fully understood all the information. Care was taken to discuss anything that was unclear to them in the brochure and/or to repeat relevant information. If necessary, patients were encouraged to contact their health care provider regarding their pain problems and/or other symptoms.

### Third home visit {#Sec7}

The third and final home visit, which took place in week 6, dealt with the same points as the second visit. Thereafter, the nurse wrote to the treating physician regarding the patient's situation. If necessary, advice was given in connection with a change in pain medication and enclosed with the report.

Measurements {#Sec8}
------------

Outcome measurements were assessed in both the intervention and control groups at baseline (T0), week 4 (T1), and week 8 (T2) (Table [1](#Tab1){ref-type="table"}). Table 1Study measurements at T0 (baseline), T1 (week 4), and T2 (week 8)Outcome measuresT0T1T2Pain intensity+++Pain knowledge++Quality of life+++Anxiety and depression++Process variables (intervention group only) Patient satisfaction+ Use of pain diary+ Use of CD+ Use of information booklet+ Medication prescription+++

*Relevant medical data* and information on other interventions that targeted pain and other symptoms were obtained from the medical records. *Pain* was measured using four questions taken from the Brief Pain Inventory (numerical rating scale) \[[@CR47]\]. This has high internal consistency with coefficient alphas ranging from 0.78 to 0.97 in various cancer population samples from different countries \[[@CR48]--[@CR57]\]. The "present" pain score was chosen as a primary outcome, since it is less subject to the biases that affect recall measurements \[[@CR58]\], and patient recall accuracy depends, in part, on the stability of the pain \[[@CR43]\].

*Patients' knowledge about pain* was measured with a translated version of Ferrell's Pain Questionnaire \[[@CR59], [@CR60]\]. The questionnaire consists of eight items, including patients are often given too much pain medication, most patients become addicted to their medication over time, and it is better to take pain medication around the clock (following a schedule) than only when needed. All the scores were converted linearly into a scale of from 0 to 100 (0 = lowest knowledge score, 100 = highest knowledge score). PKQ-DLV has demonstrated acceptable levels of validity and reliability \[[@CR43]\].

*Quality of life and nonpain symptoms* were measured using EORTC-C30 version 3 \[[@CR61]\]. EORTC-C30 is (1) cancer-specific, (2) multidimensional, (3) suitable for self-administration, and (4) applicable across a range of cultural settings. It consists of five functional scales, three symptom scales, a global health/quality of life scale, and six single items. EORTC QLQ-C30 has shown acceptable levels of validity and reliability \[[@CR61]\].

*Depression and anxiety* were measured using the Dutch version of the Hospital Anxiety and Depression Scale (HADS) \[[@CR62]\]. HADS performs well when assessing symptom severity and caseness of anxiety disorders (Cronbach's *α* = 0.68--0.93) and depression (Cronbach's *α* = 0.67--0.90) in somatic, psychiatric, and primary care patients with a sensitivity and specificity of approximately 0.80 \[[@CR63]\].

*Participation satisfaction* with the intervention was measured by asking patients the following questions: (1) Would you like to continue following the PEP? (2) Would you advise other patients to take part in the PEP? Response options were "yes" or "no."

*Use of materials* was evaluated at the end of the study by asking patients whether they had used the pain diary and the compact disc (CD) and read the information booklet. Response options were "yes" or "no."

*Advice regarding a change in pain medication* prescription at T0, T1, and T2 was analyzed by comparing the advice in the reports to the treating physician to the patients' reports about pain medication.

Statistics {#Sec9}
----------

A total of 80 patients were needed in order to ensure that the main effects of the treatment group on pain intensity could be tested adequately. Many patients would not able to complete the study, either because they would become too ill or would die. Therefore, 120 patients were recruited to ensure that 80 would complete the study. The power analysis conducted in this study was based on data from an earlier study of the PEP \[[@CR43]\]. It was necessary to have 40 patients in both the intervention and control groups in order to obtain a clinically relevant difference of 1.5 points on a ten-point scale with an alpha of 0.05, a beta of 0.20, and a standard deviation (SD) of 2.4. Data were analyzed using the Statistical Package for the Social Science version 12. Descriptive statistics were used to evaluate the demographic variables, medical variables, pain, symptoms other than pain, knowledge about pain and pain treatment, quality of life, depression, and anxiety. At T0, comparability between the intervention and control groups was analyzed using independent Student's *t* tests and chi-square tests.

Mixed regression models were used to evaluate the longitudinal data on the effects of PEP and changes over time. The high number of patients not completing this study, mainly due to severe illness and death, led to an unbalanced data set that could not be analyzed using traditional methods, such as repeated-measures analysis of variance. Mixed regression models offering an alternative for dealing with unbalanced data sets can be found in the literature \[[@CR64]\]. Therefore, the changes in outcome measures and pain over time were tested using the random intercept model.

Results {#Sec10}
=======

A total of 120 patients were entered in the study (Fig. [2](#Fig2){ref-type="fig"}). At T2, 83 of these patients had completed the follow-up. After randomization, 13 patients were excluded (eight from the control group, five from the intervention group) because they did not meet the inclusion criteria: seven patients were not suffering from cancer-related pain (arthritis, three cases; osteoporosis, one case; rheumatic disease, one case; dialysis, one case; and carpal tunnel syndrome, one case), four patients had completed their curative treatment before 2000, and one was already familiar with the PEP brochure. Data were missing at baseline, T1, or T2 in 27 patients (ten in the control group, 17 in the intervention group) (for further details, see Fig. [2](#Fig2){ref-type="fig"}). Fig. 2Flowchart of participants

No significant differences were found in the demographic characteristics, treatment group, and baseline pain levels between the intervention and control groups at baseline (Table [2](#Tab2){ref-type="table"}). Despite the randomization procedure, the baseline level of pain knowledge was significantly better in the control group than in the intervention group (*p* = 0.017). The lowest scores at baseline were observed for the item "take the lowest dose of medication possible" in both the intervention and control groups (16.9 and 27.7, respectively). No significant differences were found in the categories quality of life (except for role functioning) or prevalence of other symptoms. Table 2Baseline characteristics in the intervention group and the control group Intervention groupControl group*p* valueAge (years) Mean (SD)62.0 (10.3)60.5 (10.0)NSGender (%) Men52.138.3NS Women47.961.7NSEducation (%) Primary school77.170.2NS Secondary school6.34.3NS College/university10.423.4NS Missing6.32.1NSTreatment group (%) Group 120.827.7NS Group 258.353.2NS Group 318.817.0NS Missing2.12.1NSBaseline pain^a^4.434.71NSPain knowledge52.859.50.017*Group 1* patient is currently under curative anticancer treatment or this treatment has finished (\<5 years), *Group 2* patient is currently under palliative anticancer treatment or this is a treatment option, *Group 3* no further treatment options available^a^Present pain

Changes in the level of pain, level of pain knowledge, quality of life, anxiety, and depression {#Sec11}
-----------------------------------------------------------------------------------------------

On short-term measurement (week 4), the intervention group showed significant pain reduction (*p* = 0.02) compared to the control group (Fig. [3](#Fig3){ref-type="fig"}a). No significant (*p* = 0.14) long-term effect was seen (Table [3](#Tab3){ref-type="table"}). Fig. 3Changes in the level of pain and the level of pain knowledge in the intervention and the control group over time. **a** Changes in "present" pain over time. \**p* = 0.02. **b** Change of knowledge over time. \*^1^*p* = 0.017; \*^2^*p* \< 0.00Table 3Mean "present" pain scores in the intervention group and the control group at baseline (T0), week 4 (T1), and week 8 (T2) "Present" pain*p* valueIntervention groupControl groupMean (SD)Mean (SD)T04.71 (2.21)4.43 (2.33)0.72T1 (week 4)3.78 (2.63)4.84 (2.62)0.02T2 (week 8)4.00 (2.17)4.62 (2.25)0.14

The level of pain knowledge was measured at baseline (T0) and after 8 weeks (T2). At week 8, the level of pain knowledge was significantly better in the intervention group (*p* \< 0.00) than in the control group (Fig. [3](#Fig3){ref-type="fig"}b). Significant improvement was seen for the items "take the lowest dose of medication possible", "use of routine medication instead of on demand" and "becoming addicted" in the intervention group. Levels of pain knowledge did not improve in the control group (Table [4](#Tab4){ref-type="table"}). Table 4Mean scores on level of pain knowledge in the intervention group and control group at baseline (T0) and week 8 (T2) Level of Pain Knowledge*p* valueIntervention groupControl groupMean (SD)Mean (SD)TO52.85 (12.96)59.51 (13.64)0.017T2 (week 8)63.30 (13.10)57.05 (15.39)\<0.00

No correlation was found between the increase in pain knowledge and the change in "present" pain scores (Pearson correlation = 0.03, *p* = 0.860). Quality of life did not show any significant effects over time.

Factors relating to short-term and long-term changes in pain scores {#Sec12}
-------------------------------------------------------------------

The "present" pain intensity at baseline had a significant influence on the "present" pain intensity on short-term and long-term measurement (Fig. [4](#Fig4){ref-type="fig"}). There were no differences in pain scores at T1 (week 4) and T2 (week 8) between the intervention and control groups in patients with a baseline pain score of 1--3. At T1, pain was significantly lower in the intervention than in the control group (*p* = 0.02) in patients with a baseline pain score of 4--6. However, this difference had disappeared at T2 (*p* = 0.13). Significant differences in pain were found between the intervention and control groups at T1 (*p* = 0.00) and T2 (*p* = 0.00) in patients with a baseline score of 7--10. Fig. 4Changes in "present" pain over time in three subgroups according to baseline pain (mild, moderate, and severe baseline pain). **a** Changes in "present" pain over time in subgroups according to baseline pain in the intervention group. **b** Changes in "present" pain overtime in subgroups according to baseline in the control group

Neither gender, age, education level, severity of illness, nor baseline levels of anxiety and depression had a significant influence on the "present" pain intensity levels in either the intervention or the control group.

Adherence to advice about medication from treating physicians {#Sec13}
-------------------------------------------------------------

After the first and third home visits, the nurse reported in writing to the treating physician regarding the patient's pain problems (intensity, location, and type). In 37 cases, this report included advice in connection with a change in the pain medication regimen. In 22 of these cases, this advice was ignored. In eight cases, it was unclear whether this advice had been taken or not.

Patient opinion regarding the pain education program {#Sec14}
----------------------------------------------------

When patients with complete data sets (29 cases) were asked whether they would like to continue with the PEP, 66% replied that they would like to continue to receive support from the specialized nurse. The most important reasons for this were support and having someone available to answer questions on pain medication. The patients who did not wish continue reported that the three sessions had been enough for them to be able to follow the information on pain and pain medication. When asked whether they would advise other patients with pain complaints to take part in the PEP, all patients replied that they would. Patients' response to the third question in the pain brochure, the pain diary, and the educational CD revealed that 73% had read the pain brochure and used the pain diary.

Discussion {#Sec15}
==========

In this RCT, an intensive pain intervention program presented by nurses resulted in short-term pain reduction in patients with moderate pain at baseline and in long-term pain reduction in patients with severe pain at baseline. The intervention improved patients' knowledge of pain and pain medication. Furthermore, patients were satisfied with the intervention and would recommend it to others.

In most RCTs on educational interventions in patients, pain reduction was noted in the short-term (1 to 4 weeks) \[[@CR24]--[@CR26], [@CR29], [@CR30], [@CR33], [@CR34], [@CR37], [@CR38], [@CR40]\]. These interventions differed greatly in type and intensity, ranging from showing a video \[[@CR40]\], having a single face-to-face meeting \[[@CR25], [@CR26], [@CR34], [@CR38]\], setting up a combination of one to three face-to-face meetings and one or more telephone consultations \[[@CR24], [@CR30], [@CR33], [@CR36]\], to conducting five face-to-face meetings over 5 days \[[@CR29]\]. However, not all the results of the short-term studies were positive \[[@CR28], [@CR31], [@CR35], [@CR39]\].

Far fewer studies focused on the long-term effects. The majority did not see any long-term (6 weeks to 6 months) effects on pain intensity \[[@CR24], [@CR33], [@CR35], [@CR36], [@CR39]\]. However, one study showed improvement \[[@CR27]\] and two reported long-term pain reduction \[[@CR31], [@CR37]\]. The interventions used also differed widely in type and intensity.

The intensity of an intervention is apparently not the only effective component of a PEP, since neither the type nor the intensity could predict a positive outcome. In our study, patients with more severe pain at baseline (visual analog scale \[VAS\] scores of 7--10) achieved most benefit from the intervention, in both the short-term and long-term. In neither the intervention nor the control group did we find that gender, age, education level, severity of illness, or baseline levels of anxiety and depression significantly influenced the "present" pain intensity levels. None of the other articles studied were suitable for comparison purposes. Only one study mentioned that demographic parameters did not greatly affect the impact of the intervention, but it was unclear what these authors, in fact, meant \[[@CR32]\]. Another study classified the population according to race and found a positive short-term effect in African Americans, but not in Hispanics \[[@CR24]\].

Apart from better patient selection, other possible factors for improving the long-term effectiveness of an intervention are (1) the close involvement of family caregivers in the education program \[[@CR31], [@CR37]\] and (2) direct feedback from the nurse to the treating physician on pain levels and other problems. Aubin's study \[[@CR25]\] was the only other one in which the nurses directly communicated the results of the intervention to the patient's treating physician. However, it was unclear how they reported the results to the treating physicians and whether this had any effect. In our study, the specialized nurses wrote to the treating physicians with details of the patients' pain levels, other symptoms, and further observations. If a patient had rated their pain as VAS \> 4, the report also advised the physician to change the pain medication regimen. The contents of the advice were formulated in cooperation with a physician from the palliative care team and according to the Dutch guidelines for pain management \[[@CR65]\]. We observed that much of the advice was not followed, suggesting that this means of communication was inadequate. Possible explanations could be that the report was stored unread in the patient's medical file, too much time had elapsed between receiving the report and actual patient--physician contact, or reluctance from the physicians to follow uninvited advice. Another explanation could be insufficient involvement of the treating physicians in the implementation of the intervention. Future comparable research projects might benefit from closer communication with the treating physician. Support for this argument can be found in the study by Vallieres \[[@CR34]\]. Direct access to a physician who could adjust the analgesic regimen formed part of the intervention. Patients were clearly instructed when (at what pain level, or after three rescue doses in 24 h) to contact their doctor. In addition, they were asked to bring their pain diary with them to the consultation, to help the doctor adjust the analgesic regimen, and also to improve communication between the patient and the doctor. Although the study sample was small, the results seem to be promising. Unfortunately, no long-term effects have been reported \[[@CR34]\]. In all the above-mentioned RCTs, part of the education program was to encourage patients to talk to their treating physician about their pain. However, no data are available on the effects of patient education on communication with treating physicians.

In agreement with most of the other RCTs, our study showed an increase in pain knowledge following the intervention. In one trial, only the informal caregiver improved his knowledge \[[@CR36]\], whereas in two trials, there was no effect on pain knowledge \[[@CR35], [@CR39]\]. The rationale behind PEPs for patients is based on the presumption that better-educated patients will adhere better to their medication regimen and communicate more adequately with their treating physician. In our study, no correlation was found between an increase in pain knowledge and a decrease in pain level. In the field of cardiology, it was shown that patient education led to significantly lower levels of low-density lipoprotein cholesterol in high-risk patients (*n* = 3,053) \[[@CR66]\] and to significantly fewer admissions for heart failure \[[@CR67]\]. Three studies confirmed that fewer barriers (e.g., less fear of addiction and tolerance and a better sense of control) led to better adherence to pain medication \[[@CR26], [@CR30], [@CR31]\]. In contrast, two other studies found no correlation between decreases in barriers and pain levels \[[@CR33], [@CR69]\]. A further study (*n* = 342) showed that patients' beliefs were not associated with reports about pain or adherence to medication \[[@CR68]\]. Interventions should probably have a multifaceted design that not only incorporates education on various disease-related topics, but also implements strategies for changing patient behavior \[[@CR69]\].

Limitations {#Sec16}
===========

Our study population knew that they were enrolled in pain research, which may have stimulated both the intervention and the control group to talk about their pain with their treating physicians or other health care providers and diminished the distinction between the two groups. Another factor that might have affected comparability between the intervention and control groups is the severe illness in the patient population and the inherent inability to control disease progression.

Written communication with the treating physicians proved to be inadequate. Future research should include a more direct means of communication.

Recommendations {#Sec17}
===============

We recommend that researchers consider the following components in future education programs due to their potential ability to reduce pain levels in the longer-term: (1) Involve the patient and family caregivers as much as possible \[[@CR31], [@CR42]\]. (2) Communicate with the patient by telephone to reinforce the information and to monitor pain \[[@CR27], [@CR31], [@CR42]\]. (3) Integrate medical care into the nursing-based education program, i.e., direct contact between the nurse and the physician who can adjust the analgesic regimen. (4) Formulate clear instructions as to how and when to contact the doctor \[[@CR34]\]. (5) Have the patients keep a pain diary and let them refer to it during communication with their health care providers \[[@CR34]\].

Further research is needed to test the efficacy of the separate components and to establish the most effective intensity of PEPs. In order to investigate the exact mechanism of how pain levels can be reduced in the longer-term, we recommend that studies measure not only knowledge, pain, symptoms, and quality of life, but also the pain medication regimen \[[@CR34]\], medication adherence (e.g., by using a pillbox) \[[@CR31]\], and communication between the patients and their physicians.

Conclusions {#Sec18}
===========

This study showed that a PEP presented by nurses could lower pain intensity in cancer patients. Patients with higher pain scores benefited more from the intervention, and the effects lasted longer.

Our results support those of earlier studies in which nurses gave pain education to patients and increased their knowledge of pain. However, no correlation was found between an increase in pain knowledge and a decrease in pain level. As well as educating patients, more attention should be paid to the communication between patients and professional care providers on pain and pain management.

We are grateful to Eliane Perree and Paul Oyen, the nurses who presented the PEP to the patients.
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